China`s First Partnering Conference Draws Large Global Audience

Global Pharma and China Biotech Meet at ChinaBio® Partnering Forum in Shanghai
SHANGHAI & CARLSBAD, Calif.--(Business Wire)--
The ChinaBio® Partnering Forum, held in Shanghai, was by all measures an
unqualified success. Co-produced by ChinaBio® LLC and EBD Group, the ChinaBio®
Partnering Forum was the first biotech/pharma partnering conference held in
China, attracting 486 attendees from 274 companies and 29 countries.

Greg Scott, President and Founder of ChinaBio LLC, and Carola Schropp, President
and Founder of EBD Group, confirmed that the event significantly exceeded the
original projections of 300 attendees. "Interest was high from both sides of the
biopharma industry," said Scott, "with the global pharma looking for new drug
candidates and development platforms in China, and China`s biotech companies and
researchers seeking partnerships to develop some highly interesting novel
technologies created in China."

"Most of the global pharmaceutical companies attended the event, including
Bayer, AstraZeneca, Merck, Roche, and Pfizer, and all of them were actively
seeking partnerships," said Carola Schropp, President of EBD Group.

"More than 570 one-to-one meetings were scheduled during the Partnering Forum,
which is a very strong number for a first time event," added Schropp, whose firm
has helped to generate over 24,000 one-to-one meetings over the past year
through some of the largest and most productive partnering events for the life
science industry such as BIO-Europe, BIO-Europe Spring® and BioPharm America.

Creating cross-border partnerships was the primary theme of the ChinaBio
Partnering Forum, which took advantage of EBD Group`s web-based partneringONE
system to facilitate one-to-one meetings between attendees at the event. EBD
Group pioneered automated partnering, and the attendees, many of them first time
users of partneringONE, reported that the system was easy to use and very
effective at identifying potential partners they wished to meet.

"We had over 20 meetings during the ChinaBio Partnering Forum," said Yuwen Liu,
General Manager of BioBay in Suzhou, which is the fastest growing life science
park in China. "We have attended other major partnering events in the U.S., and
the ChinaBio Partnering Forum was very well organized and the attendees were of
very high caliber. We met several companies we expect to collaborate with in the
near future."

The ChinaBio Partnering Forum was the seventh event organized by ChinaBio LLC in
China and the first event EBD Group held in Asia. Scott said, "We felt that
bringing together our credibility with China biopharma with EBD Group`s
expertise in global life science partnering would result in a highly successful
event, and that`s exactly what happened."

Next year`s ChinaBio Partnering Forum is scheduled to be held in Suzhou at the
new Cold Spring Harbor Conference Center on June 23-24, 2010. EBD Group and
ChinaBio LLC are also organizing several other joint events, the next being
ChinaBio® Day on September 15, 2009, which is a pre-conference to EBD Group`s
BioPharm America in San Francisco.

About ChinaBio® LLC

Since its founding in January, 2007, ChinaBio LLC has rapidly launched a number
of successful initiatives connecting China biotech with the world. With offices
in Shanghai, Silicon Valley and San Diego, ChinaBio`s activities include:

* Conferences: Organizer of the premier life science investment and partnering
forums in China, which have helped early stage China companies raise over USD
100 million to date.
* Consulting: Helping global life science companies, entrepreneurs and investors
understand the China life science market, create a China strategy, and identify
novel technologies and partners.
* Information: Developing in-depth market intelligence and databases on novel
technology development, clinical trials, and investment and partnering activity
in China.
* ChinaBio® Today: Publishing online and email newsletters focusing exclusively
on China`s life science industry.

For more information please visit www.chinabiollc.com.

About EBD Group

EBD Group is the leading partnering firm for the global life science industry.
Since 1993, biotech, pharma and medical device companies have leveraged EBD
Group`s partnering conferences, technology and services to identify business
opportunities and develop strategic relationships essential to their success.

EBD Group`s conferences are run with the support of leading corporations and
international trade associations and include:

* BIO-Europe and BIO-Europe Spring®, the world's largest stand-alone life
science partnering conferences, supported by the Biotechnology Industry
Organization (BIO)
* BioPharm America, EBD Group`s North American partnering event
* EuroMedtech, EBD Group`s new partnering event for the innovative medical
technology industry
* BioEquity Europe, the investor conference co-organized with BioCentury
Publications and BIO*
* ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering
conference in China co-produced with ChinaBio LLC.

EBD Group`s sophisticated web-based partnering service, partneringONE, is used
as the partnering engine at numerous third-party events around the world.
Outside of the conference format, EBD Group`s consultants provide hands-on
assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information please visit www.ebdgroup.com.

ChinaBio LLC
Jean Meng, +1-858-926-4566 (USA) or +86-5137-0751 (China)
jmeng@chinabiollc.com
or
EBD Group
Constantine Theodoropulos, +1-617-292-7319 (USA)
ctheodoropulos@ebdgroup.com

Copyright Business Wire 2009